These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32767341)

  • 1. Inverse association between serum endocan levels and small LDL and HDL particles in patients with type 2 diabetes mellitus.
    Klisic A; Kavaric N; Vujcic S; Mihajlovic M; Zeljkovic A; Ivanisevic J; Spasojevic-Kalimanovska V; Ninic A; Kotur-Stevuljevic J; Vekic J
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8127-8135. PubMed ID: 32767341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control.
    Bojanin D; Vekic J; Milenkovic T; Vukovic R; Zeljkovic A; Stefanovic A; Janac J; Ivanisevic J; Mitrovic K; Miljkovic M; Spasojevic-Kalimanovska V
    Atherosclerosis; 2019 Jan; 280():14-20. PubMed ID: 30453116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density Lipoprotein Subclasses are Associated with Serum Uric Acid Levels.
    Moriyama K
    Clin Lab; 2018 Jul; 64(7):1137-1144. PubMed ID: 30146836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus.
    Balamir I; Ates I; Topcuoglu C; Turhan T
    Angiology; 2018 Aug; 69(7):609-616. PubMed ID: 29172652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness.
    Sabry HH; Sabry JH; Daifalla AEH; Akl EM; Hamed AM; Torky AAA
    Vasc Health Risk Manag; 2018; 14():145-152. PubMed ID: 30022835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus.
    Lv Y; Zhang Y; Shi W; Liu J; Li Y; Zhou Z; He Q; Wei S; Liu J; Quan J
    Am J Med Sci; 2017 May; 353(5):433-438. PubMed ID: 28502328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum endocan level in diabetes mellitus of patients with cirrhosis and risk of subsequent development of spontaneous bacterial peritonitis.
    Zuwala-Jagiello J; Pazgan-Simon M; Simon K; Kukla M; Murawska-Cialowicz E; Grzebyk E
    J Physiol Pharmacol; 2019 Jun; 70(3):. PubMed ID: 31539885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis.
    Shoji T; Hatsuda S; Tsuchikura S; Shinohara K; Kimoto E; Koyama H; Emoto M; Nishizawa Y
    Atherosclerosis; 2009 Feb; 202(2):582-8. PubMed ID: 18492490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality.
    Zeljkovic A; Vekic J; Spasojevic-Kalimanovska V; Jelic-Ivanovic Z; Bogavac-Stanojevic N; Gulan B; Spasic S
    Atherosclerosis; 2010 Jun; 210(2):548-54. PubMed ID: 20022325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of rs2000999 in the haptoglobin gene with total cholesterol, HDL-C, and LDL-C levels in Mexican type 2 diabetes patients.
    Suarez-Sanchez F; Vazquez-Moreno M; Herrera-Lopez E; Gomez-Zamudio JH; Peralta-Romero JJ; Castelan-Martinez OD; Cruz M; Parra EJ; Valladares-Salgado A
    Medicine (Baltimore); 2019 Sep; 98(39):e17298. PubMed ID: 31574854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study.
    Dallio M; Masarone M; Caprio GG; Di Sarno R; Tuccillo C; Sasso FC; Persico M; Loguercio C; Federico A
    J Gastrointestin Liver Dis; 2017 Sep; 26(3):261-268. PubMed ID: 28922438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocan and albuminuria in type 2 diabetes mellitus.
    Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
    Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels.
    Hayashi T; Koba S; Ito Y; Hirano T
    Lipids Health Dis; 2017 Jan; 16(1):21. PubMed ID: 28125987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Cardiovascular Risk Factors, Haematological and Biochemical Parameters, and Serum Endocan Levels in Patients with Lichen Planus.
    Ozlu E; Karadag AS; Toprak AE; Uzuncakmak TK; Gerin F; Aksu F; Ozakpınar O; Akdeniz N
    Dermatology; 2016; 232(4):438-43. PubMed ID: 27508489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between the atherosclerotic cardiovascular disease risk score used in the prediction of cardiovascular disease risk and endocan.
    Cakirca M; Dae SA; Zorlu M; Kiskac M; Tunc M; Karatoprak C
    Niger J Clin Pract; 2019 May; 22(5):713-717. PubMed ID: 31089028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of small dense lowdensity lipoprotein cholesterol in type 2 diabetics with coronary artery disease.
    Huang YC; Chang PY; Hwang JS; Ning HC
    Biomed J; 2014; 37(6):375-9. PubMed ID: 25179702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus.
    Huang J; Gu JX; Bao HZ; Li SS; Yao XQ; Yang M; Li Y; Zhang AM; Yin Y; Zhang N; Jia M; Su M
    Dis Markers; 2021; 2021():5597028. PubMed ID: 34046097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.
    Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A
    Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of small dense LDL-C/large buoyant LDL-C ratio as an independent risk factor in patients with type 2 diabetes mellitus and metabolic syndrome.
    Wang C; Li Y; Peng P; Lin H; Zhu Y; Xu X; Wu P; Zhang Y; Xu T; Ren J; Xu H; Dong G; Xu Y; Jiang H; Zhao J; Zhai Y; Zai G
    Ann Biol Clin (Paris); 2024 Jun; 82(2):174-186. PubMed ID: 38832689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.